(Q38364665)

2 September 2017

1 reference

title

Therapeutic opportunities within the DNA damage response (English)

1 reference

2 September 2017

0 references

Bissan Al-Lazikani

4

0 references

Simon E Ward

object named as

Simon E Ward

series ordinal

3

0 references

Laurence Pearl

object named as

Laurence H Pearl

series ordinal

1

0 references

Frances M. G. Pearl

series ordinal

5

object named as

Frances M G Pearl

1 reference

2 September 2017

Amanda C Schierz

2

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 March 2015

1 reference

2 September 2017

published in

Nature Reviews Cancer

1 reference

2 September 2017

volume

15

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

166-180

1 reference

The DNA damage response: ten years after

2 September 2017

cites work

1 reference

21 January 2018

Cancer genome landscapes

1 reference

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

21 January 2018

1 reference

The Cancer Genome Atlas Pan-Cancer analysis project

21 January 2018

1 reference

Synthetic lethal targeting of PTEN-deficient cancer cells using selective disruption of polynucleotide kinase/phosphatase

21 January 2018

1 reference

APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer

21 January 2018

1 reference

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

21 January 2018

1 reference

An oncogene-induced DNA damage model for cancer development

21 January 2018

1 reference

The causes and consequences of genetic heterogeneity in cancer evolution

21 January 2018

1 reference

Genetic instability and darwinian selection in tumours

21 January 2018

1 reference

The DNA damage response and cancer therapy

21 January 2018

1 reference

The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance

21 January 2018

1 reference

DNA repair dysregulation from cancer driver to therapeutic target

21 January 2018

1 reference

DNA repair pathways as targets for cancer therapy

21 January 2018

1 reference

Temozolomide: mechanisms of action, repair and resistance

21 January 2018

1 reference

Molecular mechanisms of cisplatin resistance

21 January 2018

1 reference

Definition of the intermediates and mechanism of the anticancer drug bleomycin using nuclear resonance vibrational spectroscopy and related methods

21 January 2018

1 reference

Searching for synthetic lethality in cancer

21 January 2018

1 reference

The concept of synthetic lethality in the context of anticancer therapy

21 January 2018

1 reference

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

Factors underlying sensitivity of cancers to small-molecule kinase inhibitors

21 January 2018

1 reference

A census of human cancer genes

21 January 2018

1 reference

Patterns of somatic mutation in human cancer genomes

21 January 2018

1 reference

Data, information, knowledge and principle: back to metabolism in KEGG

21 January 2018

1 reference

Reactome: a database of reactions, pathways and biological processes

21 January 2018

1 reference

STRING v9.1: protein-protein interaction networks, with increased coverage and integration

21 January 2018

1 reference

Gene ontology: tool for the unification of biology

21 January 2018

1 reference

Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair

21 January 2018

1 reference

Breast cancer proteins PALB2 and BRCA2 stimulate polymerase η in recombination-associated DNA synthesis at blocked replication forks

21 January 2018

1 reference

How many drug targets are there?

21 January 2018

1 reference

Objective assessment of cancer genes for drug discovery

21 January 2018

1 reference

Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology

21 January 2018

1 reference

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

21 January 2018

1 reference

Integrated analysis of germline and somatic variants in ovarian cancer.

21 January 2018

1 reference

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study

21 January 2018

1 reference

Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer

21 January 2018

1 reference

Familial pancreatic cancer: genetic advances

21 January 2018

1 reference

Biallelic inactivation of BRCA2 in Fanconi anemia

21 January 2018

1 reference

MoKCa database--mutations of kinases in cancer.

21 January 2018

1 reference

Deriving a mutation index of carcinogenicity using protein structure and protein interfaces

21 January 2018

1 reference

Drugging the p53 pathway: understanding the route to clinical efficacy

21 January 2018

1 reference

Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.

21 January 2018

1 reference

Signatures of mutational processes in human cancer

21 January 2018

1 reference

Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers

21 January 2018

1 reference

Mutational signatures: the patterns of somatic mutations hidden in cancer genomes

21 January 2018

1 reference

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling

21 January 2018

1 reference

A Single-Nucleotide Substitution Mutator Phenotype Revealed by Exome Sequencing of Human Colon Adenomas

21 January 2018

1 reference

Tankyrase-targeted therapeutics: expanding opportunities in the PARP family

21 January 2018

1 reference

DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1

21 January 2018

1 reference

Saccharomyces cerevisiae genetics predicts candidate therapeutic genetic interactions at the mammalian replication fork

21 January 2018

1 reference

The BioGRID interaction database: 2013 update

21 January 2018

1 reference

Building high-resolution synthetic lethal networks: a 'Google map' of the cancer cell

21 January 2018

1 reference

The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase

21 January 2018

1 reference

canSAR: updated cancer research and drug discovery knowledgebase

21 January 2018

1 reference

ChEMBL: a large-scale bioactivity database for drug discovery

21 January 2018

1 reference

Drug-like properties and the causes of poor solubility and poor permeability

21 January 2018

1 reference

Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics

21 January 2018

1 reference

Aurora kinases in head and neck cancer

21 January 2018

1 reference

Polo-like kinase 1 as target for cancer therapy

21 January 2018

1 reference

PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse

21 January 2018

1 reference

Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities

21 January 2018

1 reference

Deubiquitylating enzymes and DNA damage response pathways

21 January 2018

1 reference

Deubiquitinating enzymes as therapeutic targets in cancer

21 January 2018

1 reference

A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses.

21 January 2018

1 reference

USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis

21 January 2018

1 reference

Systematic characterization of deubiquitylating enzymes for roles in maintaining genome integrity

21 January 2018

1 reference

An evolutionarily conserved synthetic lethal interaction network identifies FEN1 as a broad-spectrum target for anticancer therapeutic development

21 January 2018

1 reference

Amino acid Asp181 of 5'-flap endonuclease 1 is a useful target for chemotherapeutic development

21 January 2018

1 reference

Complementary non-radioactive assays for investigation of human flap endonuclease 1 activity

21 January 2018

1 reference

Development of a high-throughput fluorescence polarization DNA cleavage assay for the identification of FEN1 inhibitors

21 January 2018

1 reference

A small molecule inhibitor of the BLM helicase modulates chromosome stability in human cells

21 January 2018

1 reference

Targeting an Achilles' heel of cancer with a WRN helicase inhibitor

21 January 2018

1 reference

Recessive cancer genes engage in negative genetic interactions with their functional paralogs.

21 January 2018

1 reference

A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor

21 January 2018

1 reference

DNA end-processing enzyme polynucleotide kinase as a potential target in the treatment of cancer

21 January 2018

1 reference

Structural basis for recruitment of BRCA2 by PALB2

21 January 2018

1 reference

Comprehensive molecular characterization of human colon and rectal cancer

21 January 2018

1 reference

Comprehensive genomic characterization of squamous cell lung cancers

21 January 2018

1 reference

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

21 January 2018

1 reference

Comprehensive molecular characterization of clear cell renal cell carcinoma

21 January 2018

1 reference

Comprehensive molecular characterization of urothelial bladder carcinoma

21 January 2018

1 reference

Cytoscape 2.8: new features for data integration and network visualization

21 January 2018

1 reference

Molecular mechanism of base excision repair of uracil-containing DNA in yeast cell-free extracts

21 January 2018

1 reference

DNA repair in mammalian cells: Direct DNA damage reversal: elegant solutions for nasty problems

21 January 2018

1 reference

SnapShot: DNA mismatch repair

21 January 2018

1 reference

DNA Repair: Nucleotide excision–repair in the test tube

21 January 2018

1 reference

Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function

21 January 2018

1 reference

The RSC and INO80 chromatin-remodeling complexes in DNA double-strand break repair

21 January 2018

1 reference

Replication and protection of telomeres

21 January 2018

1 reference

Men and sin: what's the difference?

21 January 2018

1 reference

Regulation of DNA damage responses by ubiquitin and SUMO.

21 January 2018

1 reference

21 January 2018

Surfing the p53 network

1 reference

Chromosome segregation in budding yeast: sister chromatid cohesion and related mechanisms.

21 January 2018

1 reference

Secondary mutations inBRCA2associated with clinical resistance to a PARP inhibitor

21 January 2018

1 reference

DNA repair: From molecular mechanism to human disease

21 January 2018

1 reference

Cancer chromosomes going to POT1

31 March 2020

1 reference

Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors

31 March 2020

1 reference

Smc5/6: a link between DNA repair and unidirectional replication?

31 March 2020

1 reference

Investigations of homologous recombination pathways and their regulation

31 March 2020

1 reference

12 December 2020

Fanconi anemia: a signal transduction and DNA repair pathway

1 reference

12 December 2020

DNA ligases as therapeutic targets

1 reference

12 December 2020

Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies.

1 reference

12 December 2020

Non-homologous DNA end joining.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3891

1 reference

Dimensions Publication ID

2 September 2017

1016272574

0 references

1 reference